Messenger RNA Quality Control Mechanism Explained
By Gerald M. Slutzky, PhD Posted on 15 Nov 2016 |
Image: Schematic of a gateway in the nuclear membrane, known as the nuclear pore complex (NPC), and the proteins (shown as spheres) involved in transport and quality control of mRNAs (shown in red). A combination of a multitude of protein-protein interactions enables the cell to distinguish and keep aberrant mRNAs from exiting the nucleus (Photo courtesy of Mohammad Soheilypour, Berkeley National Laboratory).
Genomics researchers have described a mechanism that explains how molecules of messenger RNA (mRNA) are checked for accuracy before being released from the nucleus into the cytoplasm.
Export of mRNAs into the cytoplasm is a fundamental step in gene regulation processes, which undergo quality control by highly efficient mechanisms in eukaryotic cells. However, it remains unclear how the aberrant mRNAs are recognized and retained inside the nucleus.
To better understand the quality control process, investigators at Berkeley National Laboratory (CA, USA) and the University of California, Berkeley (USA) used a new modeling approach for complex systems, namely the agent-based modeling (ABM) approach, to develop a minimal model of the mRNA quality control (QC) mechanism.
They reported in the November 2, 2016, online edition of the journal Scientific Reports that regulation of the affinity of RNA-binding proteins (RBPs) to export receptors along with the weak interaction between the nuclear basket protein (Mlp1 or Tpr) and RBPs were the minimum requirements to distinguish and retain aberrant mRNAs. The results showed that the affinity between Tpr and RBPs was optimized to maximize the retention of aberrant mRNAs.
The length of the mRNA strand affected the QC process. Since longer mRNAs spent more time in the nuclear basket to form a compact conformation and initiate their export, nuclear basket proteins could more easily capture and retain them inside the nucleus.
"Just like all production lines, the process of genetic information transfer and protein production is quality controlled at different stages," said senior author Mohammad Mofrad, professor of bioengineering and of mechanical engineering at the University of California, Berkeley. "To date, the exact mechanism of this quality control step has remained unclear. Some components of this machinery are dysregulated in various types of cancers. Understanding the molecular mechanism of genetic information transport and quality control would substantially improve the current knowledge about various types of cancers and other human diseases."
Related Links:
Berkeley National Laboratory
University of California, Berkeley
Export of mRNAs into the cytoplasm is a fundamental step in gene regulation processes, which undergo quality control by highly efficient mechanisms in eukaryotic cells. However, it remains unclear how the aberrant mRNAs are recognized and retained inside the nucleus.
To better understand the quality control process, investigators at Berkeley National Laboratory (CA, USA) and the University of California, Berkeley (USA) used a new modeling approach for complex systems, namely the agent-based modeling (ABM) approach, to develop a minimal model of the mRNA quality control (QC) mechanism.
They reported in the November 2, 2016, online edition of the journal Scientific Reports that regulation of the affinity of RNA-binding proteins (RBPs) to export receptors along with the weak interaction between the nuclear basket protein (Mlp1 or Tpr) and RBPs were the minimum requirements to distinguish and retain aberrant mRNAs. The results showed that the affinity between Tpr and RBPs was optimized to maximize the retention of aberrant mRNAs.
The length of the mRNA strand affected the QC process. Since longer mRNAs spent more time in the nuclear basket to form a compact conformation and initiate their export, nuclear basket proteins could more easily capture and retain them inside the nucleus.
"Just like all production lines, the process of genetic information transfer and protein production is quality controlled at different stages," said senior author Mohammad Mofrad, professor of bioengineering and of mechanical engineering at the University of California, Berkeley. "To date, the exact mechanism of this quality control step has remained unclear. Some components of this machinery are dysregulated in various types of cancers. Understanding the molecular mechanism of genetic information transport and quality control would substantially improve the current knowledge about various types of cancers and other human diseases."
Related Links:
Berkeley National Laboratory
University of California, Berkeley
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples